Avallano is launching ProtocolCopilot™, an innovative AI-driven clinical research protocol assistant designed to transform the way biopharmaceutical companies and clinical research sites manage and interact with complex clinical trial protocols.

ProtocolCopilot leverages advanced artificial intelligence to streamline the process of understanding and adhering to clinical research protocols. By providing a chatbot interface, it ensures that users can effortlessly access crucial protocol information without the need to navigate through cumbersome documents. Key features of ProtocolCopilotTM include:

• AI-powered Information Retrieval: Utilizes sophisticated AI to ingest, process, and respond to specific questions about a protocol, eliminating the need for manual searches and hyperlink navigation.
• Enhanced Usability: Delivers answers directly to users' questions, enabling them to bypass the time-consuming process of scanning lengthy documents.
• Memory Refresher: Facilitates quick reference checks, aiding users in recalling specific protocol procedures effortlessly.
• User-friendly Learning: Provides an engaging and intuitive platform for users to familiarize themselves with protocol details, enhancing overall user experience.
• Compliance Support: Promotes adherence to proper procedures, inclusions/exclusions, and drug-related queries, particularly under tight schedules and heavy workloads.
• Mobile Accessibility: Offers a convenient, on-the-go reference solution for busy site staff juggling multiple studies.
• Customizable Outputs: Can be tailored to provide answers in various languages and at suitable reading levels, accommodating diverse user needs.
• "Correct AI" Assurance: Implements a rigorous process to ensure that responses are factual, protocol-based, and accurate.

With ProtocolCopilot, clinical research professionals can focus more on critical tasks rather than getting bogged down by extensive protocol documents. This tool is especially beneficial for site staff who are often overwhelmed by the cognitive demands of managing numerous studies simultaneously.

"We are excited to bring ProtocolCopilotTM to the market, offering a cutting-edge solution that not only enhances efficiency but also supports compliance and accuracy in clinical research," said Paul Della Maggiora, CEO of Avallano. "By leveraging the power of AI, we are addressing a significant pain point in the industry and empowering research professionals with a tool that understands their needs."

Avallano is seeking early partners for the testing and deployment of ProtocolCopilot™.